Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 1569968)

Published in Mol Endocrinol on February 01, 1992

Authors

C A Meier1, B M Dickstein, K Ashizawa, J H McClaskey, P Muchmore, S C Ransom, J B Menke, E H Hao, S J Usala, B B Bercu

Author Affiliations

1: Molecular, Cellular and Nutritional Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Articles citing this

Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49

The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol (1995) 2.39

Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol (1997) 1.60

Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest (1994) 1.46

A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A (2001) 1.42

Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci U S A (1992) 1.41

Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression. J Clin Invest (2006) 1.37

A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. EMBO J (1998) 1.36

Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest (1993) 1.33

PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene (2008) 1.31

Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol (2007) 1.23

Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. J Clin Invest (1993) 1.11

A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10

A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci U S A (2009) 1.08

Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol (2009) 1.04

Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem (1999) 1.04

An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J Clin Invest (1993) 0.99

Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action. Proc Natl Acad Sci U S A (2005) 0.96

Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. J Clin Invest (1994) 0.96

Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol (2009) 0.96

Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids (2008) 0.95

Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene (2010) 0.94

Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity. Mol Med (1997) 0.94

The N-terminal portion of domain E of retinoic acid receptors alpha and beta is essential for the recognition of retinoic acid and various analogs. Proc Natl Acad Sci U S A (1995) 0.91

Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression. Endocrinology (2010) 0.90

Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function. J Clin Invest (1994) 0.89

Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors. Oncogene (2011) 0.88

Novel oncogenic actions of TRbeta mutants in tumorigenesis. IUBMB Life (2009) 0.86

Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription. Steroids (2006) 0.86

Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Mol Med (1995) 0.81

NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis. J Mol Endocrinol (2011) 0.80

Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor alpha. Biochem J (2001) 0.79

Mouse models of follicular and papillary thyroid cancer progression. Front Endocrinol (Lausanne) (2012) 0.76

Articles by these authors

The syndromes of resistance to thyroid hormone. Endocr Rev (1993) 3.70

Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest (1991) 2.40

Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA (1984) 2.09

Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics (1998) 1.79

The growing conundrum. Growth hormone treatment of the non-growth hormone deficient child. JAMA (1996) 1.71

Mandelate pathway of Pseudomonas putida: sequence relationships involving mandelate racemase, (S)-mandelate dehydrogenase, and benzoylformate decarboxylase and expression of benzoylformate decarboxylase in Escherichia coli. Biochemistry (1990) 1.62

Endocrine sequelae of cancer therapy in childhood. J Endocrinol Invest (2001) 1.43

Thyrotropin secreting pituitary adenoma effectively treated with octreotide. Intern Med (1998) 1.38

Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab (1991) 1.28

A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol (1991) 1.27

Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J Biol Chem (1989) 1.26

Displacement of parental RNA strands during in vitro transcription by bacteriophage phi 6 nucleocapsids. Cell (1980) 1.25

Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artificial neural networks. Radiology (2000) 1.25

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology (1992) 1.22

3-Carboxy-cis,cis-muconate lactonizing enzyme from Pseudomonas putida is homologous to the class II fumarase family: a new reaction in the evolution of a mechanistic motif. Biochemistry (1992) 1.19

Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol (Oxf) (1997) 1.16

Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab (1994) 1.15

Radiographic and CT appearances of the major fissures. Radiographics (2001) 1.13

Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. J Clin Invest (1993) 1.11

Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone nuclear receptor. Proc Natl Acad Sci U S A (1992) 1.10

Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine. J Clin Endocrinol Metab (1985) 1.04

Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab (1995) 1.04

Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab (1992) 1.03

Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormone-inhibitory element. Proc Natl Acad Sci U S A (1991) 1.02

Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun (1996) 1.01

Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid (1997) 0.99

An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J Clin Invest (1993) 0.99

Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species. J Biol Chem (1988) 0.97

Hypothalamic-pituitary dysfunction in primary empty sella syndrome in childhood. J Pediatr (1986) 0.97

Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab (1986) 0.96

A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance. J Clin Endocrinol Metab (1991) 0.96

Inhibitory effect of interferon-gamma on the response of human thyrocytes to thyrotropin (TSH) stimulation: relationship between the response to TSH and the expression of DR antigen. J Clin Endocrinol Metab (1987) 0.95

Altered cardiac phenotype in transgenic mice carrying the delta337 threonine thyroid hormone receptor beta mutant derived from the S family. Endocrinology (1999) 0.94

Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid (2000) 0.94

Circulating somatomedin-C levels in nephropathic cystinosis. Isr J Med Sci (1984) 0.94

Application of temporal subtraction for detection of interval changes on chest radiographs: improvement of subtraction images using automated initial image matching. J Digit Imaging (1999) 0.94

Phosphorylation enhances the target gene sequence-dependent dimerization of thyroid hormone receptor with retinoid X receptor. Proc Natl Acad Sci U S A (1994) 0.92

Mechanism of the reaction catalyzed by mandelate racemase. 3. Asymmetry in reactions catalyzed by the H297N mutant. Biochemistry (1991) 0.92

Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. Clin Endocrinol (Oxf) (2000) 0.91

An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity. J Clin Endocrinol Metab (1992) 0.91

Thyroid hormone and DNA binding properties of a mutant c-erbA beta receptor associated with generalized thyroid hormone resistance. Biochem Biophys Res Commun (1990) 0.89

An AP-1-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of human thyrotropin beta gene expression. J Biol Chem (1993) 0.89

Role of a pituitary-specific transcription factor (pit-1/GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-beta subunit gene expression. J Clin Invest (1992) 0.88

Multiple intrahepatic aneurysms following transcatheter arterial embolization. Work in progress. Radiology (1994) 0.87

ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid (1998) 0.86

A comparative study of foot morphology between Filipino and Japanese women, with reference to the significance of a deformity like hallux valgus as a normal variation. Ann Hum Biol (1997) 0.86

Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr (1984) 0.86

Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy. Thyroid (2000) 0.86

Cloning of the human thyrotropin beta-subunit gene and transient expression of biologically active human thyrotropin after gene transfection. Mol Endocrinol (1988) 0.86

Application of artificial neural networks for quantitative analysis of image data in chest radiographs for detection of interstitial lung disease. J Digit Imaging (1998) 0.85

Anthropometrical data of Japanese female students obtained in parallel with moiré topography. J Hum Ergol (Tokyo) (1986) 0.85

Dietary survey in Beijing in 1983. Chin Med J (Engl) (1985) 0.85

Studies on homologous desensitization of the thyrotropin receptor in 293 human embryonal kidney cells. Endocrinology (1994) 0.85

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature. Endocr J (1994) 0.85

Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding site. Biochemistry (1994) 0.85

The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res (1977) 0.84

Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities. Mol Endocrinol (1994) 0.84

Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings. Br J Radiol (2003) 0.84

Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology. Thyroid (1995) 0.84

Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren's syndrome. J Endocrinol Invest (1994) 0.84

Pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura. Intern Med (2001) 0.83

Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr (1988) 0.83

Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone. Endocrine (2001) 0.83

Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system. Endocrinology (1998) 0.83

Resistance of the male gonad to a high galactose diet. Pediatr Res (1984) 0.83

A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem (1994) 0.83

Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivors. Radiat Res (2008) 0.82

Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor. J Endocrinol Invest (1992) 0.82

Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia. Blood (1998) 0.82

An examination of the definition 'final height' for practical use. Ann Hum Biol (1998) 0.82

One-step immunoaffinity purification of human beta 1 thyroid hormone receptor with DNA and hormone binding activity. J Biochem Biophys Methods (1993) 0.82

The monomer of pyruvate kinase, subtype M1, is both a kinase and a cytosolic thyroid hormone binding protein. Biochem Biophys Res Commun (1991) 0.82

An example of variation and pattern in saltation and stasis growth dynamics. Ann Hum Biol (1998) 0.81

Male sexual development in the nonhuman primate. III. Sertoli cell culture and age-related differences. Biol Reprod (1983) 0.81

Childhood thyroid cancer: comparison of Japan and Belarus. Endocr J (1998) 0.81

Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression. Mol Endocrinol (1993) 0.81

Neutralization of gonadotropin-releasing hormone in neonatal rats with permanent impairment of the hypothalamic-pituitary-testicular axis. Biol Reprod (1982) 0.80

Detectability of peripheral lung cancer on chest radiographs: effect of the size, location and extent of ground-glass opacity. Br J Radiol (2008) 0.80

Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy. J Pediatr Endocrinol (1993) 0.80

Male sexual development in the monkey. I. Cross-sectional analysis of pulsatile hypothalamic-pituitary-testicular function. J Clin Endocrinol Metab (1983) 0.80

Cytologic characteristics of pediatric thyroid carcinoma around Chernobyl, Republic of Belarus. Acta Cytol (1997) 0.80

Diverse abnormalities of the c-erbA beta thyroid hormone receptor gene in generalized thyroid hormone resistance. Adv Exp Med Biol (1991) 0.80

Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. J Lab Clin Med (2000) 0.80

The pulse wave arrival time (QKd interval) in normal children. J Pediatr (1979) 0.80

Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid (1992) 0.80

Investigations of the metal ion-binding sites of yeast inorganic pyrophosphatase. J Biol Chem (1984) 0.80

Sequence analysis of the thyrotropin (TSH) receptor gene in congenital primary hypothyroidism associated with TSH unresponsiveness. Thyroid (1994) 0.79

A determinant of stature: regulation of growth hormone secretion. Adv Pediatr (1986) 0.79

Automated lung segmentation in digital lateral chest radiographs. Med Phys (1998) 0.79

Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol (1989) 0.79